We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
-$3.08B
(-17%)
Cap. Flow
-$4.07B
Cap. Flow
% of AUM
-27.91%
Top 10 Holdings %
Top 10 Hldgs %
20.74%
Holding
1,653
New
313
Increased
216
Reduced
349
Closed
768
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$214M |
| 2 |
Medtronic
MDT
|
+$123M |
| 3 |
Charter Communications
CHTR
|
+$97.9M |
| 4 |
Merck
MRK
|
+$94M |
| 5 |
Zoetis
ZTS
|
+$91.7M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$253M |
| 2 |
Baidu
BIDU
|
+$120M |
| 3 |
Constellation Brands
STZ
|
+$110M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$104M |
| 5 |
Abbott
ABT
|
+$98.2M |
Sector Composition
| 1 | Healthcare | 31.1% |
| 2 | Technology | 16.39% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Financials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.9T
| $487M | 3.34% |
4,254,065
-821,310
| -16% | -$89M |
|
|
2
Zoetis
ZTS
$31.6B
| $385M | 2.64% |
4,202,241
+1,034,161
| +33% | +$91.7M |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $310M | 2.13% |
690,160
+214,655
| +45% | +$84.6M |
|
4
Boston Scientific
BSX
$66.4B
| $282M | 1.94% |
7,333,396
-1,615,233
| -18% | -$56.4M |
|
5
Global Payments
GPN
$21B
| $275M | 1.89% |
2,162,102
+655,495
| +44% | +$78.8M |
|
6
UnitedHealth
UNH
$390B
| $272M | 1.87% |
1,022,572
+39,318
| +4% | +$10.2M |
|
7
S&P Global
SPGI
$130B
| $271M | 1.86% |
1,387,773
+81,878
| +6% | +$16.9M |
|
|
8
Alphabet (Google) Class A
GOOGL
$4.3T
| $270M | 1.85% |
4,468,700
+3,537,400
| +380% | +$214M |
|
9
Pfizer
PFE
$140B
| $236M | 1.62% |
5,655,623
+1,105,422
| +24% | +$42.6M |
|
10
CoStar Group
CSGP
$11.7B
| $231M | 1.58% |
5,481,940
+773,730
| +16% | +$33.1M |
|
|
11
Merck
MRK
$306B
| $228M | 1.57% |
3,368,259
+1,475,797
| +78% | +$94M |
|
|
SEE
12
DELISTED
Sealed Air
SEE
| $227M | 1.56% |
5,660,228
+326,156
| +6% | +$13.5M |
|
13
Quest Diagnostics
DGX
$23B
| $226M | 1.55% |
2,092,866
-565,264
| -21% | -$62M |
|
14
Danaher
DHR
$142B
| $176M | 1.21% |
1,830,675
+346,224
| +23% | +$31.5M |
|
15
Agilent Technologies
A
$37.9B
| $174M | 1.2% |
2,471,337
-493,983
| -17% | -$32.7M |
|
16
Carlisle Companies
CSL
$13.5B
| $172M | 1.18% |
1,415,107
-328,709
| -19% | -$40.1M |
|
17
Equifax
EFX
$20.6B
| $169M | 1.16% |
1,291,279
+403,174
| +45% | +$52.5M |
|
18
Cintas
CTAS
$73.5B
| $166M | 1.14% |
3,353,780
+728,852
| +28% | +$37.7M |
|
19
Visa
V
$680B
| $159M | 1.09% |
1,060,305
+325,768
| +44% | +$46.3M |
|
20
Cigna
CI
$80.6B
| $159M | 1.09% |
761,135
+344,859
| +83% | +$63.9M |
|
|
21
Vertex Pharmaceuticals
VRTX
$122B
| $155M | 1.07% |
804,761
-583,039
| -42% | -$104M |
|
|
BERY
22
DELISTED
Berry Global Group, Inc.
BERY
| $154M | 1.06% |
3,472,557
-654,629
| -16% | -$28.8M |
|
23
Humana
HUM
$48.7B
| $151M | 1.04% |
445,234
+155,010
| +53% | +$50.4M |
|
24
Roper Technologies
ROP
$36.4B
| $150M | 1.03% |
507,364
+124,939
| +33% | +$36.8M |
|
25
US Foods
USFD
$22.3B
| $137M | 0.94% |
4,443,836
+981,494
| +28% | +$33.9M |
|
Similar funds
TGHSA
HB
MWA
HFCIV
DVC
NAM
AIC
XEA